Too Much Insulin, Too Much Androgen, No Ovulation: The Pathophysiology of Polycystic Ovary Syndrome in a 27-Year-Old Trying to Conceive
[Student Name]
University of Phoenix
NSG/521: Advanced Pathophysiology
Week 5 Assignment
[Instructor Name]
[Date]
Composite patient written as a model document. No real patient is described.
A composite 27-year-old woman came to a women's health nurse practitioner after 14 months of trying to conceive. Since her teens she had had about six periods a year, irregular and unpredictable. She had coarse dark hair on her upper lip, chin and lower abdomen, scoring 12 on the modified Ferriman-Gallwey scale, persistent acne along her jawline and darkened, velvety skin on the back of her neck. Her body mass index was 31. Total testosterone was elevated, luteinizing hormone was high relative to follicle-stimulating hormone and a two-hour glucose tolerance test showed impaired glucose tolerance. Transvaginal ultrasound showed more than 20 small follicles in each ovary. Each of her problems, the missing periods, the unwanted hair and the difficulty conceiving, came from the same set of hormonal loops feeding one another. This paper explains the pathophysiology of polycystic ovary syndrome (PCOS) as it applies to her.
Normal Ovulation
In a normal cycle, pulses of gonadotropin-releasing hormone from the hypothalamus stimulate the pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH stimulates theca cells in the ovary to make androgens, which diffuse to neighboring granulosa cells. FSH stimulates granulosa cells to convert those androgens to estrogen through the enzyme aromatase and to select one dominant follicle. Rising estrogen triggers the midcycle LH surge, ovulation follows, and the corpus luteum produces progesterone.
Loop One: Altered Gonadotropin Signaling
In PCOS, the hypothalamus releases gonadotropin-releasing hormone in faster pulses, which favors LH over FSH. High LH drives theca cells to produce more androgen, while relatively low FSH limits the granulosa cells' ability to convert it to estrogen and to select a dominant follicle (Azziz et al., 2016). The patient's high LH relative to FSH reflects this pattern. Androgens and the absence of progesterone from ovulation in turn reduce the hypothalamus's sensitivity to negative feedback, keeping pulse frequency high, so the loop reinforces itself.
Loop Two: Ovarian Androgen Excess
Theca cells in women with PCOS are intrinsically more active in making androgens, even outside the influence of LH, suggesting a partly inherited ovarian predisposition. Excess androgen within the ovary disrupts follicle development: many small follicles begin to grow but stop at the antral stage, before any becomes dominant. These arrested follicles give the ovary its characteristic appearance on ultrasound, which explains the patient's more than 20 follicles per ovary (Azziz et al., 2016). Without a dominant follicle, there is no ovulation, which explains her infrequent periods and her difficulty conceiving.
Circulating androgens act on the skin. In hair follicles they convert fine vellus hairs into coarse terminal hairs in androgen-sensitive areas, producing hirsutism, and they stimulate sebaceous glands, producing acne.
Loop Three: Insulin Resistance
Most women with PCOS, including many who are not obese, have insulin resistance beyond what their weight would predict, with a defect in insulin signaling after the receptor in muscle and fat (Diamanti-Kandarakis & Dunaif, 2012). The pancreas compensates by secreting more insulin. Unlike muscle and fat, the ovary remains sensitive to insulin, and high insulin acts together with LH on theca cells to increase androgen production. High insulin also suppresses the liver's production of sex hormone-binding globulin, so more testosterone circulates unbound and active. Obesity worsens insulin resistance and thus amplifies the whole system.
The patient's acanthosis nigricans, the darkened skin on her neck, is a visible sign of high insulin, which stimulates keratinocyte and fibroblast growth through insulin-like growth factor receptors. Her impaired glucose tolerance shows that her compensation is beginning to fail.
How the Loops Interact
The three loops reinforce one another. Insulin raises ovarian androgen output and free testosterone. Androgens disrupt follicle development and hypothalamic feedback, keeping LH high. Androgens may also worsen insulin resistance by affecting fat distribution and muscle. Breaking any one loop, by reducing insulin, blocking androgen action or inducing ovulation directly, can improve the others, which is why treatment choices vary with the patient's goals, whether that is pregnancy, regular cycles, relief from hirsutism or prevention of diabetes.
Diagnosis
The Rotterdam criteria, still used in current international guidance, require two of three features after other causes are excluded: infrequent or absent ovulation, clinical or biochemical androgen excess and polycystic ovarian morphology (Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004). The patient meets all three. Other causes of similar findings, including thyroid disease, high prolactin, nonclassic congenital adrenal hyperplasia and androgen-secreting tumors, must be excluded; her thyroid function, prolactin and morning 17-hydroxyprogesterone were normal, and her gradual lifelong course argued against a tumor.
Why the Syndrome Varies Between Women
PCOS is heterogeneous, and the loop model explains why two women with the same diagnosis can look very different. In a lean woman with PCOS, the gonadotropin and ovarian loops may dominate, with high LH and marked androgen excess but milder insulin resistance. In a woman with obesity, the insulin loop is amplified, and metabolic features such as impaired glucose tolerance and acanthosis are more prominent, as in this patient. Some women have ovulatory dysfunction and polycystic ovaries without clinical androgen excess, while others have striking hirsutism with only mildly irregular cycles. Genetic studies suggest that many variants, each with a small effect, influence hypothalamic signaling, ovarian steroid production and insulin action, which fits a condition with several interacting causes rather than one. Recognizing which loops dominate in a given woman helps predict her risks and tailor her treatment.
Long-Term Consequences
The mechanism predicts the long-term risks. Without ovulation, the endometrium is exposed to estrogen without the regular shedding that progesterone withdrawal causes, raising the risk of endometrial hyperplasia and cancer over time. Insulin resistance raises the risk of type 2 diabetes, gestational diabetes and cardiovascular risk factors, and the psychological burden of hirsutism, acne and infertility contributes to higher rates of anxiety and depression.
How the Mechanism Guides Treatment
Because her goal is pregnancy, treatment targets ovulation. Letrozole, an aromatase inhibitor, lowers estrogen briefly, which reduces negative feedback on the pituitary, raises FSH and helps a single follicle become dominant. Legro et al. (2014), in a large randomized trial in women with PCOS, found that letrozole produced higher live birth rates than clomiphene, and letrozole is now the recommended first-line oral agent for ovulation induction in PCOS. Addressing the insulin loop also helps: a modest weight loss of 5% to 10% through diet and activity can restore ovulation in some women, and metformin can improve insulin sensitivity, although it is less effective than letrozole for achieving pregnancy.
Conclusion
In this 27-year-old woman, faster hypothalamic signaling raised LH, intrinsically active theca cells and insulin-driven stimulation increased androgen production, and excess androgen stopped follicles from maturing. The result was infrequent ovulation, hirsutism, acne and polycystic-appearing ovaries, with acanthosis nigricans and impaired glucose tolerance revealing the insulin resistance underneath. Understanding PCOS as interacting loops explains her findings, her long-term risks and why letrozole, supported by weight loss and attention to insulin, is the logical first step toward pregnancy.
References
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016). Polycystic ovary syndrome. Nature Reviews Disease Primers, 2, Article 16057. https://doi.org/10.1038/nrdp.2016.57
Diamanti-Kandarakis, E., & Dunaif, A. (2012). Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and implications. Endocrine Reviews, 33(6), 981-1030. https://doi.org/10.1210/er.2011-1034
Legro, R. S., Brzyski, R. G., Diamond, M. P., Coutifaris, C., Schlaff, W. D., Casson, P., Christman, G. M., Huang, H., Yan, Q., Alvero, R., Haisenleder, D. J., Barnhart, K. T., Bates, G. W., Usadi, R., Lucidi, S., Baker, V., Trussell, J., Krawetz, S. A., Snyder, P., ... Zhang, H. (2014). Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine, 371(2), 119-129. https://doi.org/10.1056/NEJMoa1313517
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility, 81(1), 19-25. https://doi.org/10.1016/j.fertnstert.2003.10.004
How this NSG 521 Week 5 example is structured
The University of Phoenix library guide for NSG/521 lists Week 5 as Gastrointestinal and Gynecologic, with infertility among the research topics. The paper presents PCOS as a system of reinforcing loops rather than a single cause, because that is how current evidence explains it and because each loop maps to a finding in the case. The diagnostic criteria come after the mechanism so they can be understood as its visible signs, and the treatment section shows how the mechanism guides the choice of therapy. Students search this week as NSG 521 Week 5, NSG521 Wk 5 or NSG/521 Wk 5; all three are the same assignment.
NSG/521 Week 5 questions, answered
What does NSG/521 Week 5 usually ask for?
The library guide for NSG/521 lists Week 5 as gastrointestinal and gynecologic, with topics that include inflammatory bowel disease, GERD, colon cancer, celiac disease, hepatitis, sexually transmitted infections and infertility. Many sections ask for a paper explaining the pathophysiology of one such condition in a patient.
Do women with PCOS always have cysts on their ovaries?
No. The "cysts" are arrested antral follicles, not true cysts, and polycystic ovarian morphology is only one of three diagnostic features. A woman can meet the criteria with irregular ovulation and androgen excess and normal-appearing ovaries.
Why does insulin resistance matter in PCOS if the patient does not have diabetes?
High insulin levels act directly on the ovary to increase androgen production and lower the liver's production of sex hormone-binding globulin, raising free testosterone. Insulin resistance also raises the long-term risk of type 2 diabetes and cardiovascular disease.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official University of Phoenix document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.